Duchenne’s muscular dystrophy (DMD) is a recessive, X-linked skeletal muscle disorder that is characterised by muscle tissue weakness and wasting. In DMD, muscle cells lose the ability to regenerate in response to injury, and ultimately undergo necrosis. Amyotrophic lateral sclerosis is another condition in which the regenerative capacity of skeletal muscle cells is impaired, but, in this case, muscle loss occurs via atrophy. In light of recent evidence that biomaterials mimicking healthy extracellular matrix can enhance regeneration, Kuraitis et al. explored the therapeutic potential of a collagen-based matrix in mice. Treatment with the matrix promoted skeletal muscle regeneration in vivo and in vitro; however, the positive effects were observed only in a necrotic environment. This study provides a promising new therapy for skeletal muscle disorders that involve active necrosis, such as DMD. Page 793
Biomaterial promotes muscle cell regeneration in vivo Open Access
Biomaterial promotes muscle cell regeneration in vivo. Dis Model Mech 1 May 2013; 6 (3): 556. doi:
Download citation file:
Advertisement
Cited by
Call for papers – In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery

We invite you to submit your latest research to our upcoming special issue: In Vitro Models of Human Disease to Inform Mechanism and Drug Discovery, coordinated by DMM Editor Vivian Li (The Francis Crick Institute, London, UK), alongside Guest Editors Austin Smith (University of Exeter, UK) and Joseph Wu (Stanford University School of Medicine, USA).The deadline for submitting articles is 6 October 2025.
The Company of Biologists Workshops

For the last 15 years, our publisher, The Company of Biologists, has provided an apt environment to inspire biology and support biologists through our Workshops series. Read about the evolution of the Workshop series and revisit JEB's experience with hosting the first Global South Workshop.
Read & Publish Open Access publishing: what authors say

We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Fast & Fair peer review

Our sister journal Biology Open has recently launched the next phase of their Fast & Fair peer review initiative: offering high-quality peer review within 7 working days. To learn more about BiO’s progress and future plans, read the Editorial by Daniel Gorelick, or visit the Fast & Fair peer review page.
Propose a new Workshop for 2027

We are currently seeking proposals for Workshops to be held in 2027. As one of the scientific organisers of a The Company of Biologists Workshop, your involvement will be focused on interdisciplinary, cutting-edge science and promoting new partnerships and collaborations. We focus on the logistics. Are you thinking about proposing a topic for one of our Workshops? Apply by Friday 30 May 2025.
Other journals from
The Company of Biologists